Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study of the GORE® Multibranch Arch Endoprosthesis (MBA Device)

NCT07564375 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT07564375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07564375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study of the GORE® Multibranch Arch Endoprosthesis (MBA Device)
Lead sponsor
W.L.Gore & Associates
Phase
Not applicable
Overall status
Recruiting
Start date
September 2, 2026
Completion date
August 31, 2033
Enrollment
20 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

penetrating aortic ulcers (paus), pseudoaneurysm, thoracic aortic aneurysm, thoracic aortic dissection